Neuberger Berman Group
GH icon

Neuberger Berman Group’s Guardant Health GH Stock Holding History

Neuberger Berman Group’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.5M Sell
76,608
-64,103
-46% -$6.97M 0.01% 853
2026
Q1 		$13M Buy
140,711
+9,692
+7% +$973K 0.01% 759
2025
Q4 		$13.4M Buy
131,019
+2,618
+2% +$234K 0.01% 744
2025
Q3 		$8.02M Buy
128,401
+42,701
+50% +$2.32M 0.01% 856
2025
Q2 		$4.46M Sell
85,700
-46,835
-35% -$2.09M ﹤0.01% 996
2025
Q1 		$5.65M Buy
132,535
+125,874
+1,890% +$5.43M ﹤0.01% 916
2024
Q4 		$203K Buy
+6,661
New +$187K ﹤0.01% 1795
2022
Q4 		– Sell
-15,124
Closed -$814K – 1823
2022
Q3 		$814K Buy
15,124
+4,917
+48% +$252K ﹤0.01% 1317
2022
Q2 		$411K Sell
10,207
-82,493
-89% -$4.09M ﹤0.01% 1544
2022
Q1 		$6.14M Buy
92,700
+7,439
+9% +$509K 0.01% 915
2021
Q4 		$8.07M Buy
85,261
+10,064
+13% +$1.04M 0.01% 869
2021
Q3 		$8.94M Buy
75,197
+16,542
+28% +$1.97M 0.01% 831
2021
Q2 		$6.9M Buy
58,655
+1,414
+2% +$190K 0.01% 886
2021
Q1 		$8.28M Buy
57,241
+4,658
+9% +$704K 0.01% 854
2020
Q4 		$6.44M Buy
52,583
+14,540
+38% +$1.67M 0.01% 858
2020
Q3 		$3.98M Sell
38,043
-17,303
-31% -$1.58M ﹤0.01% 904
2020
Q2 		$4.4M Buy
55,346
+6,675
+14% +$538K 0.01% 853
2020
Q1 		$3.39M Buy
48,671
+12,257
+34% +$941K 0.01% 852
2019
Q4 		$2.85M Sell
36,414
-96,088
-73% -$6.92M ﹤0.01% 954
2019
Q3 		$8.46M Buy
132,502
+3,784
+3% +$333K 0.01% 746
2019
Q2 		$11.1M Buy
+128,718
New +$9.83M 0.01% 737

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Neuberger Berman Group's GH Position: Q2 2026 in Review

Neuberger Berman Group reduced its Guardant Health (GH) stake by 46% in Q2 2026, selling an estimated $6.97M and leaving 76,608 shares worth $11.5M. The position accounts for 0.01% of the portfolio, ranked #853.

Neuberger Berman Group first reported a position in GH in Q2 2019 and has held it in 21 quarters since. The position peaked at $13.4M in Q4 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Neuberger Berman Group held 76,608 shares of Guardant Health worth $11.5M as of Q2 2026.
  • Neuberger Berman Group sold 64,103 Guardant Health shares in Q2 2026, an estimated $6.97M.
  • Guardant Health made up 0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #853 holding.
  • Neuberger Berman Group first reported a position in Guardant Health in Q2 2019 and has held it in 21 quarters since.
  • Neuberger Berman Group's Guardant Health position peaked at $13.4M in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.